Skip to main content
Clinical Trials/NCT00969605
NCT00969605
Completed
Phase 4

Adaptive Support Ventilation for Faster Weaning in COPD: A Randomized Controlled Trial

Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital1 site in 1 country97 target enrollmentApril 2007

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Pulmonary Disease, Chronic Obstructive
Sponsor
Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital
Enrollment
97
Locations
1
Primary Endpoint
Weaning duration
Status
Completed
Last Updated
15 years ago

Overview

Brief Summary

Adaptive support ventilation (ASV) is a closed loop ventilation mode that can act both as pressure support (PSV) and pressure controlled (PCV) ventilation. Weaning with ASV shows promising results mainly in post-cardiac surgery patients. The aim of this randomized controlled study was to test the hypothesis that weaning with ASV could reduce the weaning duration in patients with chronic obstructive pulmonary disease (COPD) when compared with PSV.

Registry
clinicaltrials.gov
Start Date
April 2007
End Date
December 2008
Last Updated
15 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of COPD
  • On invasive mechanical ventilation for at least 24 hours because of hypoxemic and/or hypercapnic respiratory failure

Exclusion Criteria

  • Mechanical ventilation less then 24 hours (self extubation or death),
  • Having a tracheotomy and
  • COPD coexisted with severe cardiac or neurologic diseases.

Outcomes

Primary Outcomes

Weaning duration

Secondary Outcomes

  • Weaning success
  • Length of stay in the ICU

Study Sites (1)

Loading locations...

Similar Trials